152 related articles for article (PubMed ID: 19321511)
1. Clinical expression of leflunomide-induced pneumonitis.
Chikura B; Lane S; Dawson JK
Rheumatology (Oxford); 2009 Sep; 48(9):1065-8. PubMed ID: 19321511
[TBL] [Abstract][Full Text] [Related]
2. Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
Atzeni F; Boiardi L; Sallì S; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2013 Jul; 9(7):649-57. PubMed ID: 23899235
[TBL] [Abstract][Full Text] [Related]
3. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
Roubille C; Haraoui B
Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
[TBL] [Abstract][Full Text] [Related]
5. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Sawada T; Inokuma S; Sato T; Otsuka T; Saeki Y; Takeuchi T; Matsuda T; Takemura T; Sagawa A;
Rheumatology (Oxford); 2009 Sep; 48(9):1069-72. PubMed ID: 19321513
[TBL] [Abstract][Full Text] [Related]
6. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
7. [Acute interstitial pneumonia in patient with rheumatoid arthritis treated with leflunomide].
Siemion-Szcześniak I; Bartoszuk I; Bartosiewicz M; Jakubowska L; Wesołowski S; Kuś J
Pneumonol Alergol Pol; 2014; 82(6):568-75. PubMed ID: 25339568
[TBL] [Abstract][Full Text] [Related]
8. Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review.
Keng LT; Lin MW; Huang HN; Chung KP
Medicine (Baltimore); 2016 Jun; 95(26):e4044. PubMed ID: 27368035
[TBL] [Abstract][Full Text] [Related]
9. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
[TBL] [Abstract][Full Text] [Related]
10. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
11. Variation of immunological response in methotrexate-induced pneumonitis.
Chikura B; Sathi N; Lane S; Dawson JK
Rheumatology (Oxford); 2008 Nov; 47(11):1647-50. PubMed ID: 18812430
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
Narváez J; Díaz-Torné C; Ruiz JM; Hernández MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM
Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung disease related to rheumatoid arthritis: evolution after treatment.
Rojas-Serrano J; González-Velásquez E; Mejía M; Sánchez-Rodríguez A; Carrillo G
Reumatol Clin; 2012; 8(2):68-71. PubMed ID: 22341526
[TBL] [Abstract][Full Text] [Related]
14. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
15. Pneumonitis associated with leflunomide: a profile of New Zealand and Australian reports.
Savage RL; Highton J; Boyd IW; Chapman P
Intern Med J; 2006 Mar; 36(3):162-9. PubMed ID: 16503951
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
Ohosone Y; Okano Y; Kameda H; Fujii T; Hama N; Hirakata M; Mimori T; Akizuki M; Ikeda Y
J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.
Sato T; Inokuma S; Sagawa A; Matsuda T; Takemura T; Otsuka T; Saeki Y; Takeuchi T; Sawada T;
Rheumatology (Oxford); 2009 Oct; 48(10):1265-8. PubMed ID: 19651883
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis associated with methotrexate-induced pneumonitis: improvement with i.v. cyclophosphamide therapy.
Suwa A; Hirakata M; Satoh S; Mimori T; Utsumi K; Inada S
Clin Exp Rheumatol; 1999; 17(3):355-8. PubMed ID: 10410272
[TBL] [Abstract][Full Text] [Related]
19. Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease.
Horai Y; Miyamura T; Shimada K; Takahama S; Minami R; Yamamoto M; Suematsu E
J Clin Pharm Ther; 2012 Feb; 37(1):117-21. PubMed ID: 21128990
[TBL] [Abstract][Full Text] [Related]
20. [Rheumatoid arthritis and lung - more than a minor aspect of the disease].
Fiehn C
Dtsch Med Wochenschr; 2015 Jun; 140(12):904-7. PubMed ID: 26069917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
